SMITH-VAN VURST ANDREW, COO, reported a transaction classified as exercise at BioStem Technologies, Inc. involving 250000.000000 shares for an estimated $500000.00. Reported holdings after the transaction were 1789809.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
Form 4 relationship flags and nearby filing context
Chief Operating Officer
The Series A-1 Convertible Preferred Shares are convertible in whole into shares of the Issuer's Common Stock on a one-to-one basis at the option of a majority of the holders of Series A-1 Convertible…
The Series A-1 Convertible Preferred Shares have no expiration date.
Due to an administrative error, the Series A-1 Convertible Preferred Shares were inadvertently omitted from the Reporting Person's Form 3 filed on August 14, 2026.
These options are fully vested and exercisable.
These options vest according to the following schedule: 33% vested on March 17, 2026, the one-year anniversary of the grant date, with the remaining options vesting in equal quarterly installments ove…
These options vest according to the following schedule: 33% will vest on October 13, 2026, the one-year anniversary of the grant date, with the remaining options vesting in equal quarterly installment…
These options vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installmen…
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
These restricted stock units will vest in equal quarterly installments over three years from the grant date (September 15, 2024).
These restricted stock units vest according to the following schedule: 33% vested on March 17, 2026, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly ins…
These restricted stock units vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining units vesting in equal quarter…
0 other filings
0 recent txs